| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8444065 | European Journal of Cancer | 2013 | 11 Pages |
Abstract
This is the largest study of HBV reactivation in patients receiving rituximab-containing chemotherapy to date, and we defined the probability of HBV reactivation in an HBV-endemic region.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Seok Jin Kim, Chiun Hsu, Yu-Qin Song, Kevin Tay, Xiao-Nan Hong, Junning Cao, Jin Seok Kim, Hyeon Seok Eom, Joon Hyeok Lee, Jun Zhu, Kian-Meng Chang, Arry Harryanto Reksodiputro, Daryl Tan, Yeow Tee Goh, Jejung Lee, Tanin Intragumtornchai, Wee-Joo Chng,